Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT05138653 | A Single and Multiple Ascending Dose Trial of CVL-354 in Healthy Participants | PHASE1 | COMPLETED | 73 | — | — | Oct 1, 2021 | Jan 1, 2023 | Nov 25, 2024 | - | — |
| Name | Type | Description |
|---|---|---|
| CVL-354 | DRUG | Oral solution/suspension |
| Placebo | DRUG | Placebo matched to CVL-354 |